Check out the latest Women's Health news, including interviews and press releases here.
Press Release: New Survey Finds Women Are Skipping Their OB/GYN Exams, Increasing Risks for Cervical Cancer
Women Are Seeking More Convenience and Less Discomfort in Testing Options
FRANKLIN LAKES, N.J., Jan. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the results of a new survey, revealing that 72% of women in the United States have delayed having a gynecology visit, with many highlighting the need for greater convenience, comfort and ease for this critical cervical cancer screening process.
Press Release: Women in U.S. can now collect their own sample for cervical cancer screening
In a significant advancement for women's health, BD today announced FDA approval for the use of self-collected vaginal specimens for HPV testing, allowing women to self-collect vaginal samples for human papillomavirus (HPV) testing in a health care setting, which could include non-traditional locations such as a retail pharmacy or mobile clinic.
This new approval of self-collected samples opens the door to a less invasive testing option and improves access to testing for individuals who face barriers to cervical cancer screening.
New BD survey finds nearly half of women unaware of STI treatment options
Featured in FiercePharma, new Harris Poll findings reveal women want to be more informed by their HCPs when it comes to STIs, testing and treatment options.
New Harris Poll Finds Women Want More Education on Sexually Transmitted Infections Testing and Treatment
BD released findings from a survey conducted online by The Harris Poll, reporting that women feel less knowledgeable about testing and treatment options for sexually transmitted infections (STIs) compared to other vaginal diseases and infections.
Business Insider: Getting the HPV vaccine and regular testing can help protect you from high-risk HPV strains that cause cancer
Dr. Jeff Andrews, VP Medical Affairs, Integrated Diagnostic Solutions, shares statistics with Business Insider about knowledge gaps in cervical cancer causes and tests.
Press Release: BD Onclarity™ HPV Assay Receives FDA Approval for Use with Both BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap Test
The BD Onclarity™ HPV Assay has received FDA Approval for use with both BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap Test, which expands access to the HPV test that more precisely identifies patients’ risk for cervical cancer.
Contemporary OB/GYN: Harris Poll study from BD reveals knowledge gap and inequity in HPV screening and cervical cancer
In Contemporary OB/GYN, Dr. Jeff Andrews, VP Medical Affairs, shares findings from a Harris Poll noting gaps in women's knowledge about HPV and cervical cancer.
POLITICO: Women don’t know when to get screened for cervical cancer, survey finds
Dr. Jeff Andrews, VP Medical Affairs, Integrated Diagnostic Solutions, shares insights in POLITICO from a survey conducted by The Harris Poll noting significant gaps in women’s understanding about the causes and prevention of cervical cancer.
POV: The U.S. healthcare system is failing Black and Latina women
In this Fast Company op-ed, Brooke Story, BD Integrated Diagnostic Solutions president, challenges and encourages the advocacy for strengthening health care systems, improving testing infrastructure and delivering the highest quality care, regardless of race, geographic location, or socioeconomic status.
Stay up-to-date with the latest news from BD Women's Health!
